Who is sponsoring STCC?

STCC is sponsored by Cadila Pharnmaceuticals.

What drugs are being tested in STCC?

Interventions: Mycobacterium w, BCG (Bacillus Calmette-Guerin).

Last reviewed 2021-08-17 · How we verify

Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder (STCC)

NCT00694915 PHASE2 COMPLETED

The purpose of this study is to determine and compare the effect of this treatment on recurrence rate and to assess the toxicity in both arms of patients with STCC. Other objectives include determining the effects of this treatment on quality of life, and comparing the effect of Mycobacterium w on time to tumor progression.

Details

Lead sponsor	Cadila Pharnmaceuticals
Phase	PHASE2
Status	COMPLETED
Enrolment	122
Start date	Thu Aug 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Oct 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Bladder Cancer

Interventions

Mycobacterium w
BCG (Bacillus Calmette-Guerin)

Countries

India